Literature DB >> 2653459

Sézary cell morphology induced in peripheral blood lymphocytes: re-evaluation.

A C Chu1, J F Morris.   

Abstract

In this study we examined the effect of mitogens and epidermal cells in inducing a Sézary cell morphology in normal peripheral blood lymphocytes. Peripheral blood mononuclear cells from six healthy volunteers were stimulated with the mitogens phytohemaglutinin and concanavalin A, and also cocultivated with human epidermal cell cultures. Incubation times with mitogens and epidermal cells were four days and stimulation of the lymphocytes by mitogens was confirmed by standard 3H-thymidine uptake. Standard transmission electron microscopy showed that in the mitogen-driven system 20% to 60% (33 +/- 15%) and in the epidermal cell-driven system 5% to 15% (8 +/- 4%) of the lymphoid cells exhibited mild to moderate indentation of the nuclei with nuclear contour indices (NCI) of 4.6 to 6.5 but no Sézary cells were observed (cells with NCI greater than 6.5 and up to 19.2). In the mitogen-stimulated preparation 2% to 5% (3 +/- 1%) of the lymphoid cells showed nuclear multilobulation resembling the cells seen in adult T cell lymphoma/leukemia. Incubation of mononuclear cells for longer periods of up to 4 weeks with mitogens and exogenous IL-2 resulted in no further morphologic changes. Using an indirect immunogold technique at the electron microscopic level, the cells showing nuclear indentation or lobulation were shown to bear both T helper (CD4) and T suppressor (CD8) cell phenotypes in a similar ratio to the total numbers of T helper and T suppressor cells present. Mitogens and epidermal cells are thus not able to induce a morphologic change to Sézary cells in normal peripheral blood lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653459

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  1 in total

1.  Anti-CD antibody microarray for human leukocyte morphology examination allows analyzing rare cell populations and suggesting preliminary diagnosis in leukemia.

Authors:  Alina N Khvastunova; Sofya A Kuznetsova; Liubov S Al-Radi; Alexandra V Vylegzhanina; Anna O Zakirova; Olga S Fedyanina; Alexander V Filatov; Ivan A Vorobjev; Fazly Ataullakhanov
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.